A trial using PET scans to test the anti-inflammatory drug PIPE-791 finished enrolling healthy volunteers and patients with ...

In healthy adults, a single low dose of IMP761 continues to be safe and appears to reduce the activity of T-cells, a clinical ...

Older men with MS who used androgen-modifying therapies showed unexpectedly sustained or increased disease activity in a ...

Heat sensitivity makes July 4 columnist Leigh Anne Nelson's least favorite holiday. This year, she'll be listening to her ...

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

Mitochondrial abnormalities, or problems in cells' powerhouses, contribute to nerve cell death linked to motor control in MS, ...

At first, I couldn’t recall a major traumatic event in my past. But when I examined more deeply, I realized that my early ...

New advanced imaging technology that detects specific molecules in the brain may find signs of MS lesions months earlier, a ...

Columnist Desiree Lama pens an open letter to her present-day self, who is in need of some support and encouragement while ...

The first person with multiple sclerosis was imaged in a clinical trial of a PET tracer to track myelin changes.

In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate ...

Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.